Long-standing refractory polymyositis responding to mycophenolate mofetil: A case report and review of the literature

Clinical Rheumatology

Volumn 26, Issue 10, 2007, Pages 1795-1796

  Caramaschi, Paola ^a   Volpe, Alessandro ^a   Carletto, Antonio ^a   Bambara, Lisa M ^a   Biasi, Domenico ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

Mycophenolate mofetil; Polymyositis

Indexed keywords

AZATHIOPRINE; CREATINE KINASE; IMMUNOGLOBULIN; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID;

ADD ON THERAPY; ADULT; ARTHRALGIA; ARTICLE; CASE REPORT; CLINICAL FEATURE; CREATINE KINASE BLOOD LEVEL; DERMATOMYOSITIS; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; ELECTROMYOGRAPHY; FEMALE; FEVER; HISTOPATHOLOGY; HUMAN; MUSCLE BIOPSY; MUSCLE WEAKNESS; MYALGIA; PRIORITY JOURNAL; TREATMENT RESPONSE; BIOPSY; INFLAMMATION; METABOLISM; POLYMYOSITIS; TREATMENT OUTCOME;

ADULT; BIOPSY; FEMALE; HUMANS; IMMUNOGLOBULINS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION; MYCOPHENOLIC ACID; POLYMYOSITIS; TREATMENT OUTCOME;

EID: 38449092486     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-006-0526-5     Document Type: Article

References (16)

1. TM Chan FK Li CS Tang, et al. 2000 Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group N Engl J Med 343 1156 1162 11036121 10.1056/ NEJM200010193431604 1:CAS:528:DC%2BD3cXnsleqs7w%3D (Pubitemid 30781986)
2. V Majithia V Harisdangkul 2005 Mycophenolate mofetil (CellCept): an alternative therapy for autoimmune inflammatory myopathy Rheumatology 44 386 389 15572389 10.1093/rheumatology/keh499 1:CAS:528:DC%2BD2MXhslSksLw%3D (Pubitemid 40361299)
3. AC Gelber HC Nousari FM Wigley 2000 Mycophenolate mofetil in the treatment of severe skin manifestations of dermatomyositis: a series of 4 cases J Rheumatol 27 1542 1545 10852287 1:STN:280:DC%2BD3cvotlGgsg%3D%3D
4. J Rowin AA Amato N Deisher J Cursio MN Meriggioli 2006 Mycophenolate mofetil in dermatomyositis: is it safe? Neurology 66 1245 1247 16636243 10.1212/01.wnl.0000208416.32471.c0 1:CAS:528:DC%2BD28XjtFOrtLo%3D (Pubitemid 43739712)
5. MA Waldman JP Callen 2004 Self-resolution of Epstein-Barr virus-associated B-cell lymphoma in a patient with dermatomyositis following withdrawal of mycophenolate mofetil and methotrexate J Am Acad Dermatol 51 Suppl 2 S124 S130 15280831 10.1016/j.jaad.2004.03.020
6. JC Edge JD Outland JR Dempsey JP Callen 2006 Mycophenolate mofetil as an effective corticosteroid-sparing therapy for recalcitrant dermatomyositis Arch Dermatol 142 65 69 16415388 10.1001/archderm.142.1.65 1:CAS:528: DC%2BD28XhtVOjsb0%3D (Pubitemid 43107363)
7. I Labioche E Liozon B Weschler V Loustaud-Ratti P Soria E Vidal 2004 Refractory polymyositis responding to infliximab: extended follow-up Rheumatology 43 531 532 15024143 10.1093/rheumatology/keh079 1:STN:280:DC%2BD2c7jt1WhsA%3D%3D (Pubitemid 38489380)
8. CK Saadeh 2000 Etanercept is effective in the treatment of polymyositis/dermatomyositis which is refractory to conventional therapy including steroid and other disease modifying agents Arthritis Rheum 43 S193
9. GJD Hengstam FHJ Van Der Hoogen P Barbera, et al. 2003 Anti-TNF blockade with infliximab (Remicade) in polymyositis and dermatomyositis Eur Neurol 50 10 15 10.1159/000070852 (Pubitemid 36736963)
10. I Uthman J El-Sayad 2004 Refractory polymyositis responding to infliximab Rheumatology 43 1198 1199 15317962 10.1093/rheumatology/keh268 1:CAS:528:DC%2BD2cXntFagsLc%3D (Pubitemid 39232833)
11. A Anandacoomarasamy G Howe N Manolios 2005 Advanced refractory polymyositis responding to infliximab Rheumatology 44 562 563 15695299 10.1093/rheumatology/keh539 1:STN:280:DC%2BD2M7ks1ylsw%3D%3D (Pubitemid 41511155)
12. I Marie P Heliot F Roussel F Herve JF Muir H Levesque 2005 Fatal mycobacterium peregrinum pneumonia in refractory polymyositis treated with infliximab Rheumatology 44 1201 1202 15941728 10.1093/rheumatology/keh700 1:STN:280:DC%2BD2MvkslWgtg%3D%3D (Pubitemid 41236037)
13. E Roddy PA Courtney A Morris 2002 Non-Hodgkin's lymphoma in a patient with refractory dermatomyositis which had been treated with infliximab Rheumatology 41 1194 1195 12364644 10.1093/rheumatology/41.10.1194 1:STN:280:DC%2BD38nhtVSntw%3D%3D
14. R Wilkes SM Sereika N Fertig, et al. 2005 Treatment of antisynthetase-associated interstitial lung disease with tacrolimus Arthritis Rheum 52 2439 2446 16052580 10.1002/art.21240 1:CAS:528:DC%2BD2MXpslGht7w%3D (Pubitemid 41117430)
15. JE Gottenberg L Guillevin O Lambotte, et al. 2005 Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases Ann Rheum Dis 64 913 920 15550531 10.1136/ard.2004.029694 1:CAS:528: DC%2BD2MXls1alsLw%3D (Pubitemid 40733918)
16. O Lambotte R Kotb G Maigne, et al. 2005 Efficacy of rituximab in refractory polymyositis J Rheumatol 32 1368 1370